Deborah H. Telman - 10 Mar 2025 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
EVP, Corporate Affairs & GC
Signature
/s/ Edward S. Son by Power of Attorney for Deborah H. Telman
Issuer symbol
GILD
Transactions as of
10 Mar 2025
Transactions value $
-$132,447
Form type
4
Filing time
12 Mar 2025, 19:08:15 UTC
Previous filing
06 Feb 2025
Next filing
28 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +3.34K +9.73% 37.7K 10 Mar 2025 Direct F1
transaction GILD Common Stock Tax liability -$132K -1.13K -3% $117.21 36.6K 10 Mar 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -3.34K -12.07% 24.4K 10 Mar 2025 Common Stock 3.34K Direct F1, F3
transaction GILD Non-qualified Stock Option (Right to Buy) Award $0 +33.9K $0.00 33.9K 10 Mar 2025 Common Stock 33.9K $117.21 Direct F4
transaction GILD Restricted Stock Unit Award +7.68K +31.3% 32.2K 10 Mar 2025 Common Stock 7.68K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 Balance adjusted to reflect shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan.
F3 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F4 The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.